Newsletter March 2024
Dear Colleague,
Will you be attending AACR in San Diego this year? We look forward to having you join us for a fun evening reception at the East Village Brewing Company on Monday April 8th! We will start at 7 pm with some welcome drinks followed by a short introduction to EPO’s newest developments.
Afterwards, we invite you to enjoy delicious burgers, wine and crafted beer and to connect with us and colleagues.
As space is limited, please sign up with Turn on Javascript!
We also proudly present our brand new scientific developments during the poster sessions. Stop by and chat with our experts about your drug development plans and how our preclinical tumor models and expertise can help advance your program.
Title: Integrated tumor models for immune oncology using live cell imaging for prediction of treatment efficacy in vitro and in vivo
Poster Section on 28, Poster Board 5 presented on Monday Apr 8, 9:00 AM - 12:30 PM
Title: Assessment of therapeutic antibody efficacy without the interference of murine Fc receptors allows for investigation of human antibody-dependent cellular cytotoxicity mediated by NK cells in the FcResolv™ hIL-15 NOG mouse model
Poster Section 10, Poster Board 23 presented on Monday Apr 8, 1:30 PM - 5:00 PM
Title: Humanization of NOG mice and next-generation NOG strains to induce lineage-specific differentiation of immune cells for assessment of novel immune cell therapies, check point inhibitors, and immune cell engagers for translational immuno-oncology research
Poster Section 4, Poster Board 14 presented on Tuesday Apr 9, 1:30 PM - 5:00 PM
We look forward to seeing you during the reception and our poster session!
Best wishes,
Jens Hoffmann & Wolfgang Walther
CEO & CSO at EPO